GlobeNews Wire

Melexis: update on the share buy-back program

December 15, 2025 11:45 ET  | Source: Melexis N.V. Press release - Regulated Information Ieper, Belgium – 15 December 2025,…

3 months ago

Society Pass Incorporated (Nasdaq: SOPA) Rolls Out M&A Strategy to Capture Potential Significant Valuation Opportunities in Global Landscape of Privately Held Companies

December 15, 2025 10:55 ET  | Source: Society Pass Incorporated NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- As part…

3 months ago

Rpharmy Honored With Family Business Award From Austin Business Journal

Austin-Based Healthcare Technology Provider Recognized for Community Impact, Life-Saving Solutions that Protect Patients, Healthcare Workers December 15, 2025 10:55 ET…

3 months ago

Face-Art Maestro Dr Jaffer Khan Pioneers Aesthetic Artistry for Advanced Plastic Surgery in Dubai

DUBAI, United Arab Emirates, Dec. 15, 2025 (GLOBE NEWSWIRE) -- In Dubai, Dr. Jaffer Khan is redefining plastic surgery, elevating…

3 months ago

Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer

AGOURA HILLS, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) in collaboration with the Brush and Key…

3 months ago

Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances

December 15, 2025 09:15 ET  | Source: Trinity Biotech plc Company advances its mission to deliver next-generation diabetes management solutions…

3 months ago

Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods

BRISBANE, Australia and CAMBRIDGE, Mass., Dec. 14, 2025 (GLOBE NEWSWIRE) -- Australian biotechnology pioneer Vaxxas Pty Ltd, has been granted…

3 months ago

InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the…

3 months ago

Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026

December 12, 2025 16:30 ET  | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) --…

3 months ago

Mutuum Finance (MUTM) Completes Smart Contracts in Preparation for Q4 2025 Testing

Dubai, UAE, Dec. 14, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a decentralized finance (DeFi) project focused on lending and…

3 months ago